about
Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African GabonSeroprevalence of Toxocara spp. in a rural population in Central African Gabon.Dalbavancin for outpatient parenteral antimicrobial therapy of skin and soft tissue infections in a returning traveller : Proposal for novel treatment indications.Single dose treatment of malaria - current status and perspectives.Artemether-lumefantrine for the treatment of Plasmodium malariae, Plasmodium ovale, and mixed Plasmodium malaria: A prospective clinical trial assessing species-specific efficacy in Gabon.Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.A common trap of diagnostic tests : Disease prevalence and positive predictive value.Behavioural and clinical predictors for Loiasis.Detection of the Malaria causing Plasmodium Parasite in Saliva from Infected Patients using Topoisomerase I Activity as a Biomarker.Preliminary Evidence for the Absence of Cystic Echinococcosis in Gabon: A Cross-Sectional Pilot Survey in Humans and Definitive Hosts.Validity and reliability of methods to microscopically detect and quantify malaria parasitaemiaUse of Capillary Blood Samples Leads to Higher Parasitemia Estimates and Higher Diagnostic Sensitivity of Microscopic and Molecular Diagnostics of Malaria than Venous Blood SamplesLeishmaniasis in Northern Syria during Civil WarRefined Method for Droplet Microfluidics-Enabled Detection of Plasmodium falciparum Encoded Topoisomerase I in Blood from Malaria PatientsMeasles, Vaccines, and Types of Perception Bias in Public DebatesProspective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission SettingRibavirin for the treatment of Lassa fever: A systematic review and meta-analysis
P50
Q36262884-7E6C2C63-9A68-4655-A2A7-7381E9043510Q39197276-114BE691-830E-4112-BDF5-F04F4718BF87Q39253970-BE51D803-F035-4BBC-B310-24C013B98C49Q39253978-5816EB2D-ECD4-419B-B54F-A22A01C6F1B4Q47556680-DED7B386-5A3A-44C1-859A-29BC0B3FB143Q47666846-018D1D2D-315D-4CB4-A431-C8B1CE17B003Q48227191-1A0434C3-AC8B-4B69-972F-9FDB220DAC30Q50333992-47BEB808-8274-43E8-96B6-0FDAE4749C27Q52668559-E4CDC66C-AD07-45B2-ABE5-A5276240A83CQ54203231-125B3E6E-5FAC-42DA-B823-0FF4FAD3504DQ56374642-9842E7D4-0AAD-4EBD-A2E1-751D4DBC7439Q56379959-E1F648CD-B9DF-491B-8CF3-00DC15DCDA5EQ58550519-889D52F0-F704-437E-A02B-D26DE8392E73Q62139220-1D1D998C-CC48-4BD8-9A38-E7D47D2C3F78Q91824209-B8A8503C-295C-4C6A-B64D-8B89EBAE4122Q91845026-7E56E2F7-B9EC-48F3-B825-074AF5F6C48AQ92254698-C1B007F9-C941-4FED-89FF-58312E46C0E7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johannes Mischlinger
@ast
Johannes Mischlinger
@en
Johannes Mischlinger
@es
Johannes Mischlinger
@nl
Johannes Mischlinger
@sl
type
label
Johannes Mischlinger
@ast
Johannes Mischlinger
@en
Johannes Mischlinger
@es
Johannes Mischlinger
@nl
Johannes Mischlinger
@sl
prefLabel
Johannes Mischlinger
@ast
Johannes Mischlinger
@en
Johannes Mischlinger
@es
Johannes Mischlinger
@nl
Johannes Mischlinger
@sl
P106
P1153
56946890400
P31
P496
0000-0002-2012-6327